Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,299 signal articles · 46 in last 24h · 115,565 total before filter · latest 55m ago
46last 24h
1764last 7d
300● bullish (7d)
168● bearish (7d)
205publishers
AllMacro314Earnings818M&A103Regulatory25Product16Analyst26
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Arlo Technologies Q2 Earnings Call Highlights
MarketBeat8d agoneutral
Arlo Technologies Q2 Earnings Call Highlights

Arlo Technologies (NYSE:ARLO) reported record second-quarter results, citing growth in subscription services, paid accounts and total revenue as the company raised its full-year 2026 outlook. Chief Executive Officer Matt McRae said service revenue, total revenue, gross profit and non-GAAP net incom

Albemarle Q2 Earnings Call Highlights
MarketBeat8d agoneutral
Albemarle Q2 Earnings Call Highlights

Albemarle (NYSE:ALB) reported higher second-quarter sales, earnings and cash generation as lithium pricing improved and its specialties business benefited from stronger pricing and volumes. Second-quarter net sales rose 31% from a year earlier to $1.7 billion, while adjusted EBITDA more than double

Ziff Davis Q2 Earnings Call Highlights
MarketBeat8d agoneutral
Ziff Davis Q2 Earnings Call Highlights

Ziff Davis (NASDAQ:ZD) said its second-quarter results reflected continued pressure in search-driven advertising businesses, partially offset by growth in several operating areas, while the company moved to reshape its capital structure following the sale of its Connectivity business. During the qu

BlackSky Technology (BKSY) Could Be 31% Undervalued As Strong Earnings Back Guidance
Simply Wall St.8d agoneutral
BlackSky Technology (BKSY) Could Be 31% Undervalued As Strong Earnings Back Guidance

BlackSky Technology (BKSY) stock is in focus after the company reported second quarter 2026 results that combined 50.1% year over year revenue growth, a narrower loss, and reaffirmed full year revenue guidance of US$130 million to US$150 million. See our latest analysis for BlackSky Technology. BlackSky Technology's latest earnings announcement and reaffirmed revenue guidance have coincided with a sharp rebound in the stock, with a 1-day share price return of 10.37% and 7-day share price...

Xenon Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat9d agoneutral
Xenon Pharmaceuticals Q2 Earnings Call Highlights

10x Genomics reported second-quarter revenue of $151 million, including $1.6 million in license and royalty revenue tied to its settlement with Takara Bio. Excluding non-recurring settlement revenue in both periods, revenue was $149.4 million, up 3% from the prior-year quarter. Chief Executive Offi